Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Tumor Resection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07206511
What this trial is testing

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

Who this might be right for
Unresectable Hepatocellular Carcinom
Shanghai Zhongshan Hospital 278
Testing effectiveness (Phase 2)WithdrawnNCT00408772
What this trial is testing

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of California, Davis
Post-approval studies (Phase 4)Looking for participantsNCT06398028
What this trial is testing

The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.

Who this might be right for
Liver Tumor; Surgery
Hospital Universitari Vall d'Hebron Research Institute 173
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Not applicableUnknownNCT01542281
What this trial is testing

Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer

Who this might be right for
Colorectal NeoplasmBiliary Tract NeoplasmLiver Neoplasm
McGill University Health Centre/Research Institute of the McGill University Health Centre 64
Post-approval studies (Phase 4)UnknownNCT00768157
What this trial is testing

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusRecurrence
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Study completedNCT00003753
What this trial is testing

Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02849145
What this trial is testing

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Who this might be right for
Uveal Melanoma
Institut Curie 60
Not applicableNot Yet RecruitingNCT07297615
What this trial is testing

3D Liver Volumetry

Who this might be right for
Liver SurgeryLiver CancerSurgical Planning+3 more
Medical University of Graz 25
Not applicableStudy completedNCT07180641
What this trial is testing

National Registry of Hepatic Metastases From Non-Colorectal Cancer"

Who this might be right for
Non-colorectal Liver MetastasisLiver MetastasisNon-neuroendocrine Liver Metastasis+5 more
Clinica Universidad de Navarra, Universidad de Navarra 1,039
Not applicableUnknownNCT01924624
What this trial is testing

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRecurrence
The First Affiliated Hospital of Xiamen University 140
Early research (Phase 1)UnknownNCT05352646
What this trial is testing

NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Newish Technology (Beijing) Co., Ltd. 26
Large-scale testing (Phase 3)Study completedNCT00692770
What this trial is testing

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 1,114
Early research (Phase 1)Study completedNCT00003431
What this trial is testing

Flt3L in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Duke University
Not applicableUnknownNCT06271109
What this trial is testing

Short Term Surgical Outcomes of Anatomical Versus Non Anatomical Laparoscopic Liver Resection for Liver Tumors

Who this might be right for
Liver Neoplasms
Sohag University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03847428
What this trial is testing

Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 908
Testing effectiveness (Phase 2)Ended earlyNCT01775267
What this trial is testing

ALLPS VERSUS PVO Randomized Controlled Trial

Who this might be right for
Liver Tumors Not Resectable in One Surgical Procedure
University of Zurich 7
Not applicableUnknownNCT02886104
What this trial is testing

Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis

Who this might be right for
Secondary Malignant Neoplasm of Liver
Sixth Affiliated Hospital, Sun Yat-sen University 548
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07522411
What this trial is testing

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
BinYong Liang 100
Testing effectiveness (Phase 2)UnknownNCT01055743
What this trial is testing

The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma

Who this might be right for
Early Stage Hepatocellular Carcinoma
Simcere Pharmaceutical Co., Ltd 250
Next Page